Institutional investors purchased a net $10.0 million shares of MDCO during the quarter ended September 2015 and now own 121.32% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 7.6 Million shares of Medicines Co
ANTIPODEAN ADVISORS LLC Bought 2.4 Million shares of Medicines Co
MILLENNIUM MANAGEMENT LLC Bought 2.0 Million shares of Medicines Co